Semaglutide Compounding Dispute: Novo Nordisk Heads To Court

The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.

SA Pharma Localisation Faces Foreign Investor Pressure

SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement.